TipRanks
Faeth Therapeutics (DE:4070)
FRANKFURT:4070
Germany Market
4070
Faeth Therapeutics
RESEARCH TOOLSreports

Faeth Therapeutics (4070) Income Statement

1 Followers

Faeth Therapeutics Income Statement

Last quarter (Q2 2026), Faeth Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Faeth Therapeutics's net income was $-16.01M. See Faeth Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -551.00K$ -571.00K$ -1.81M$ -685.00K
Operating Expenses
$ 22.29M$ 31.11M$ 36.49M$ 47.31M$ 36.80M
Depreciation and Amortization
$ 139.00K$ 551.00K$ 3.68M$ 1.81M$ 685.00K
EBITDA
$ -20.91M$ -29.52M$ -33.39M$ -46.56M$ -35.44M
Operating Income
$ -22.29M$ -31.66M$ -37.06M$ -49.12M$ -37.48M
Other Income/Expenses
$ 1.20M$ 1.51M$ 2.96M$ 532.00K$ 688.00K
Pretax Income
$ -21.09M$ -30.16M$ -34.10M$ -48.59M$ -36.79M
Net Income
$ -21.09M$ -30.16M$ -34.10M$ -48.59M$ -36.79M
Per Share Metrics
Basic EPS
$ -16.72$ -24.01$ -24.40$ -31.65$ -26.56
Diluted EPS
$ -16.72$ -24.01$ -24.40$ -31.65$ -26.56
Weighted Average Shares Outstanding
 1.26M 1.26M 1.40M 1.54M 1.39M
Weighted Average Shares Outstanding (Diluted)
 1.26M 1.26M 1.40M 1.54M 1.39M
Currency in USD

Faeth Therapeutics Earnings and Revenue History